Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis.
BACKGROUND
Sarcoidosis is an inflammatory disease of unknown etiology. However, an infectious cause has been proposed suggesting a role for pattern-recognition receptors, such as Toll-like receptors (TLRs) and nucleotide-binding domain, leucin-rich repeat containing family proteins (NLRs), in the pathogenesis.


OBJECTIVE
Our aim was to investigate whether differences in TLR2 and TLR4 expression, and the response to TLR2, TLR4, and NOD2 stimulation, are associated with sarcoidosis.


METHODS
Blood mononuclear cells from sarcoidosis patients (n = 24) and healthy subjects (n = 19) were incubated with the TLR2 ligands PGN and Pam3CSK4, the TLR4 ligand LPS, the NOD2 ligand MDP, or medium alone. After 16 h, monocyte TLR2 and TLR4 expression and cytokine secretion, including TNFalpha, IL-1 beta, IL-6, IL-8, IL-10, and IL-12p70, were measured using flow cytometry and cytometric bead array.


RESULTS
TLR2 and TLR4 expression at baseline was significantly higher in patients. Combined TLR2 and NOD2 stimulation induced a four-fold higher secretion of TNFalpha and a 13-fold higher secretion of IL-1 beta in patients. Additionally, there was a synergistic effect of TLR2 with NOD2 stimulation on induction of IL-1 beta in patients, whereas IL-10 was synergistically induced in healthy subjects.


CONCLUSIONS
Increased TLR expression and enhanced secretion of pro-inflammatory cytokines after combined TLR2 and NOD2 stimulation may be related to the pathogenesis of sarcoidosis.
Wikén
Maria
M
Department of Medicine, Respiratory Medicine Unit, Karolinska Institutet, Lung Research Laboratory L4:01, Karolinska University Hospital, Solna, 171 76, Stockholm, Sweden. Maria.Wiken@ki.se
Grunewald
Johan
J
Eklund
Anders
A
Wahlström
Jan
J
D000328:Adult; D002478:Cells, Cultured; D016207:Cytokines / Q000096:biosynthesis / Q000187:drug effects / Q000276:immunology*; D005260:Female; D006801:Humans; D008024:Ligands; D055666:Lipopeptides / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009000:Monocytes / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D053473:Nod2 Signaling Adaptor Protein / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D012507:Sarcoidosis / Q000276:immunology* / Q000378:metabolism; D051195:Toll-Like Receptor 2 / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*; D051197:Toll-Like Receptor 4 / Q000187:drug effects / Q000276:immunology / Q000378:metabolism*
D016207:Cytokines; D008024:Ligands; D055666:Lipopeptides; D008070:Lipopolysaccharides; D053473:Nod2 Signaling Adaptor Protein; C508075:Pam(3)CSK(4) peptide; D051195:Toll-Like Receptor 2; D051197:Toll-Like Receptor 4
J Invest Dermatol. 2005 May;124(5):931-8
15854033
Lancet. 2002 Aug 10;360(9331):465-6
12241724
J Leukoc Biol. 2006 Apr;79(4):860-6
16461743
Lancet. 1992 Apr 25;339(8800):1012-5
1349051
Clin Exp Immunol. 2001 Oct;126(1):151-6
11678912
PLoS Pathog. 2005 Nov;1(3):279-85
16322770
Nat Genet. 2001 Sep;29(1):19-20
11528384
Clin Exp Immunol. 2008 Jun;152(3):423-31
18422738
Biochim Biophys Acta. 2006 Sep;1762(9):794-801
16935475
Immunobiology. 1996-1997;196(5):522-34
9145330
Semin Immunol. 2004 Feb;16(1):35-41
14751762
J Endocrinol. 2007 Jun;193(3):323-30
17535871
Clin Exp Immunol. 2006 Aug;145(2):215-8
16879239
Sarcoidosis Vasc Diffuse Lung Dis. 2006 Mar;23(1):23-9
16933467
Clin Exp Immunol. 2007 Sep;149(3):453-62
17565608
Blood. 2005 Feb 1;105(3):1195-7
15459013
Cell Microbiol. 2005 Jan;7(1):53-61
15617523
Thorax. 1988 Jul;43(7):516-24
2850637
Arthritis Rheum. 2004 May;50(5):1457-67
15146415
Nature. 2001 May 31;411(6837):603-6
11385577
Acta Med Scand. 1952 Mar 19;142(4):265-73
14932794
Am J Respir Crit Care Med. 1999 Aug;160(2):736-55
10430755
J Immunol. 2005 May 15;174(10):6518-23
15879155
Mol Immunol. 2004 Nov;41(11):1099-108
15476921
Proc Am Thorac Soc. 2007 Aug 15;4(5):457-60
17684289
Int Arch Allergy Appl Immunol. 1991;96(1):68-75
1752698
Respir Res. 2005 Jul 08;6:68
16004610
Zentralbl Bakteriol Mikrobiol Hyg A. 1984 Apr;256(4):541-7
6377763
Am J Respir Cell Mol Biol. 2004 Oct;31(4):463-9
15242847
J Exp Med. 2005 Mar 7;201(5):755-67
15753209
Cell Death Differ. 2006 May;13(5):798-815
16528382
Eur J Immunol. 1990 Aug;20(8):1661-7
1976520
J Leukoc Biol. 2001 Jun;69(6):1036-44
11404392
Am J Respir Crit Care Med. 1997 Nov;156(5):1601-5
9372682
Nat Immunol. 2004 Aug;5(8):800-8
15220916
Am J Ophthalmol. 2003 Nov;136(5):933-5
14597055
Clin Chest Med. 1997 Dec;18(4):681-94
9413652
Eur Respir J. 2006 Mar;27(3):451-9
16507843
Thorax. 1987 Jun;42(6):420-6
3660300
Blood. 2002 May 1;99(9):3427-31
11964313
Biochim Biophys Acta. 1998 Mar 13;1396(3):320-35
9545592
J Biol Chem. 2003 Feb 21;278(8):5509-12
12514169